E E Bliven

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment
    E E Bliven-Sizemore
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Int J Tuberc Lung Dis 16:473-9. 2012
  2. ncbi request reprint The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection
    E E Bliven
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Int J Tuberc Lung Dis 13:1054-60. 2009

Collaborators

  • M E Villarino
  • E E Bliven-Sizemore
  • W J Burman
  • R E Chaisson
  • S Goldberg
  • J L Johnson

Detail Information

Publications2

  1. doi request reprint Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment
    E E Bliven-Sizemore
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Int J Tuberc Lung Dis 16:473-9. 2012
    ..Both trials enrolled human immunodeficiency virus (HIV) infected participants who were not receiving antiretroviral therapy (ART) at TB treatment initiation...
  2. ncbi request reprint The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection
    E E Bliven
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Int J Tuberc Lung Dis 13:1054-60. 2009
    ..To examine chronic viral hepatitis (CVH) as a risk factor for hepatotoxicity during isoniazid (INH) treatment for latent tuberculosis infection (LTBI)...